Theodoros N. Teknos, MD, has been named Director of the Division of Head and Neck Oncologic Surgery at Ohio State University College of Medicine. Dr. Teknos, who comes from the University of Michigan where he was Division Chief of Head and Neck Oncology in the Department of Otolaryngology, is bringing three of his top researchers with him to OSU: Quintin Pan, PhD; Pawan Kumar, PhD; and Mozaffar Islam, PhD.
Also at OSU, Michael A. Caligiuri, MD, CEO of the James Cancer Hospital and Solove Research Institute and Director of the Comprehensive Cancer Center there, is now on the National Cancer Institute's Board of Scientific Advisors.
The National Institutes of Health has awarded the University of Georgia (UGA) a five-year, $8.3 million grant to further its research into the role cell-surface sugars known as glycans play in the development of stem cells and cancer cells. The grant allows UGA to continue its role as a National Center for Research Resources Center for Biomedical Glycomics, a designation the university received in 2003 after receiving a $6.2 million grant from the agency.
Subha Madhavan, PhD, has been named the first Director of Clinical Research Informatics and Research Assistant Professor of Oncology at Georgetown University's Lombardi Comprehensive Cancer Center.
Alex A. Adjei, MD, PhD, Senior Vice President of Clinical Research and the Katherine Anne Gioia Chair in Cancer Medicine at Roswell Park Cancer Institute (RPCI), has been named Chair of a newly launched NCI trial to determine if biomarkers can help guide therapies for non-small cell lung cancer. The study, called MARVEL (Marker Validation for Erlotinib in Lung Cancer), is the first that will establish whether a biomarker can identify an epidermal growth factor receptor target as well as the effectiveness of drugs to block the target.
RPCI has also added the following physicians to its staff: Nefertiti du Pont, MD, MPH, Department of Gynecologic Oncology; Katerina Gurova, MD, PhD, Department of Cell Stress Biology; and Levi Ross, PhD, MPH, Department of Health Disparities.
Pediatric cancer specialist Sinisa Dovat, MD, has received a $330,000 grant from the St. Baldrick's Foundation to study the causes of acute myeloid leukemia. Dr. Dovat, who is a professor in the School of Medicine and Public Health, will investigate how the elevated activity of enzymes in protein can generate malignant cells that trigger AML.
Judy Chatigny, RN, MSN, has been named Vice President of Patient Access Services at City of Hope. Ms. Chatigny, who serves on the Executive Board of the American Cancer Society and is a member of the Association of Cancer Executives, Association of Community Cancer Centers, and Oncology Nursing Society, was previously Executive Director at Loma Linda University Cancer Center.
Fox Chase Cancer Center has appointed the following physicians: to the Department of Surgical Oncology, Robert A. Burger, MD, Co-Director of the Ovarian Cancer Research Program; to the Medical Oncology staff, Attending Physicians Adam Cohen, MD, and Elizabeth Plimack, MD; and to the Department of Medicine, Stephen J. Heller, MD, Attending Physician in the Gastroenterology Section, and Karen Y. Mechanic, MD, Director of Psychiatry.
The National Institute of Environmental Health Sciences has awarded Emory University's Winship Cancer Institute a five-year $7.4 million grant to support their work examining links between oxidative stress and colorectal cancer. Paul Doetsch, PhD, Professor of Biochemistry, Radiation Oncology, and Hematology and Oncology at Emory University School of Medicine, is the grant's principal investigator.
US Oncology has presented the following individuals with its 2008 Awards of Excellence in Clinical Operations:
- Eric Palmer, RN, OCN, of Texas Oncology-Amarillo, the Pearl Moore Excellence in Nursing Leadership Award.
- Marion Smith, RN, OCN, of Texas Cancer Center-Abilene, the Betsy York Memorial Oncology Certified Nurse of the Year Award.
- Nancy Egerton, PharmD, BCOP, of New York Oncology Hematology; Chris Sellers, RPh, of Texas Oncology-Wichita Falls Texoma Cancer Center; James Gallman, RPh, DDS, of Texas Oncology-Plano East, the Outstanding Achievement in Pharmacy Award.
- Stacey Bryant, RT, CMD, of Cancer Care Centers of South Texas; Kimberly George, RT, of Kansas City Cancer Centers; and Jennifer Jones, RT, of Texas Oncology-Tyler Cancer Center, the Outstanding Achievement in Radiation Oncology and Imaging Award.
- Brian D. Wichman, DABR, of Kansas City Cancer Centers, the Outstanding Achievement in Medical Dosimetry and Physics Award.
- Lisa Bruehahn-Propernick, RT, of Rocky Mountain Cancer Centers, the Outstanding Achievement in Radiation Oncology and Imaging Management Award.
© 2008 Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...